Tag: Johnson & Johnson

• Saturday, June 12th 2021 - 09:00 UTC

  Some 60 million doses of US produced J&J Covid-19 “can't be used because of possible contamination”

  

  Johnson & Johnson was informed by the US Food and Drug Administration that millions of doses of the Covid-19 vaccine produced at a troubled plant can't be used because of possible contamination issues.

• Tuesday, April 20th 2021 - 15:02 UTC

  Big Pharma companies gross 152bn dollars since the beginning of the pandemic

  

  Despite setbacks with patients dying or suffering from undesired side effects which led to the suspension of some vaccines in various countries, the market value of pharmaceutical companies continues to rise, having amassed 152 billion US dollars in profits since the beginning of the coronavirus pandemic, it was reported.

• Thursday, March 4th 2021 - 08:47 UTC

  White House financial support for Merck and Johnson & Johnson to speed vaccine production

  

  White House senior adviser Andy Slavitt told reporters on Tuesday that the federal government is planning to spend US$100 million to help the joint partnership between Merck & Co and rival Johnson & Johnson accelerate vaccine production.

• Wednesday, March 3rd 2021 - 08:56 UTC

  Merck & Co to the rescue of Johnson & Johnson single shot Covid-19 vaccine

  

  Merck & Co will help make rival Johnson & Johnson's single-shot Covid-19 vaccine in a partnership set to be announced on Tuesday by US President Joe Biden, a White House official said. J&J's vaccine production has been slower than promised.

• Monday, November 16th 2020 - 08:56 UTC

  Johnson & Johnson launches test trial of its two-dose Covid-19 vaccine in Britain

  

  Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental COVID-19 vaccine among thousands of volunteers, as the U.S. drugmaker expands its trials by geography and type.

• Wednesday, November 4th 2020 - 08:46 UTC

  Johnson & Johnson resumes clinical trials of the Covid-19 vaccine in Brazil

  

  Brazilian health regulator Anvisa has authorized the resumption of a clinical trial of Johnson & Johnson's experimental COVID-19 vaccine, according to a statement from the government agency on Tuesday.

• Friday, August 28th 2020 - 08:59 UTC

  J&J added Chile, Argentina and Peru volunteers to conduct trials for its vaccine against Covid-19

  

  United States pharmaceutical company Johnson & Johnson has added Chile, Argentina, and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19, the company confirmed on Wednesday.

• Wednesday, August 19th 2020 - 09:58 UTC

  Brazil approved human clinical trials for a potential Johnson & Johnson Covid-19 vaccine

  

  Brazil approved on Tuesday human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson, the fourth candidate to trial in the Latin American country that has become key to the global race for a vaccine.

• Thursday, July 9th 2020 - 07:59 UTC

  Campaign to stop Johnson&Johnson selling its talk Baby Powder worldwide

  

  More than 170 nonprofit groups on Wednesday called for Johnson & Johnson to stop selling its talc-based Johnson’s Baby Powder world-wide, citing concerns that it contains cancer-causing asbestos, according to a statement from advocacy group Black Women for Wellness.

• Thursday, May 21st 2020 - 07:58 UTC

  J&J will stop selling its talk based Baby Powder because of 16.000 lawsuits claiming it is carcinogenic

  

  Johnson & Johnson on Tuesday announced that it would stop selling its talc-based Johnson's Baby Powder in the United States and Canada, saying it was part of a broad reassessment of its consumer product portfolio prompted by the coronavirus pandemic.